Canagliflozin

Results: 21



#Item
11September 2, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg

September 2, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg

Add to Reading List

Source URL: www.daiichisankyo.com

Language: English - Date: 2014-09-21 22:38:31
12INVOKAMET™ (canagliflozin and metformin hydrochloride) tablets for oral use[removed]

INVOKAMET™ (canagliflozin and metformin hydrochloride) tablets for oral use[removed]

Add to Reading List

Source URL: www.invokanahcp.com

Language: English - Date: 2014-10-09 12:19:03
13Canagliflozin: New Medication for Type 2 Diabetes Mellitus Canagliflozin (trade name Invokana) has been approved for monotherapy or combination therapy with other oral hypoglycemics and insulin for the treatment of type

Canagliflozin: New Medication for Type 2 Diabetes Mellitus Canagliflozin (trade name Invokana) has been approved for monotherapy or combination therapy with other oral hypoglycemics and insulin for the treatment of type

Add to Reading List

Source URL: medsask.usask.ca

Language: English - Date: 2014-07-15 15:35:38
14HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA™ safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA™ safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets,

Add to Reading List

Source URL: www.invokanahcp.com

Language: English - Date: 2014-05-23 17:07:54
15MEDICATION GUIDE INVOKANA™ (in-vo-KAHN-uh) (canagliflozin) Tablets What is the most important information I should know about INVOKANA?

MEDICATION GUIDE INVOKANA™ (in-vo-KAHN-uh) (canagliflozin) Tablets What is the most important information I should know about INVOKANA?

Add to Reading List

Source URL: www.invokanahcp.com

Language: English - Date: 2014-05-06 04:06:44
16Microsoft Word - 20140704_Approval for CANAGLU_E_Final.doc

Microsoft Word - 20140704_Approval for CANAGLU_E_Final.doc

Add to Reading List

Source URL: www.daiichisankyo.com

Language: English - Date: 2014-07-09 23:53:06
17田辺三菱製薬プレスリリース・テンプレート設定用

田辺三菱製薬プレスリリース・テンプレート設定用

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-05-26 10:08:55
18April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes

April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-04-01 21:51:25
19June 16, 2014 Press release Mitsubishi Tanabe Pharma Corporation Positive Phase 3 Results of Canagliflozin in Japanese Patients with Type 2 Diabetes at American Diabetes Association

June 16, 2014 Press release Mitsubishi Tanabe Pharma Corporation Positive Phase 3 Results of Canagliflozin in Japanese Patients with Type 2 Diabetes at American Diabetes Association

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2014-06-15 21:20:21
20July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval in Japan Received for

July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval in Japan Received for

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2014-07-04 01:18:30